We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Copart
CPRT
$27.5B
| $3.59M | 0.02% |
103,620
-2,652
| -2% | -$94.8K |
|
577
Lloyds Banking Group
LYG
$91.3B
| $3.57M | 0.02% |
1,459,220
-10
| -0% | -$24 |
|
578
Xcel Energy
XEL
$48.8B
| $3.56M | 0.02% |
56,994
+36,186
| +174% | +$2.44M |
|
579
Microchip Technology
MCHP
$46B
| $3.54M | 0.02% |
46,184
+5,344
| +13% | +$401K |
|
580
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.49B
| $3.54M | 0.02% |
29,667
+569
| +2% | +$70.3K |
|
581
iShares Silver Trust
SLV
$30.7B
| $3.53M | 0.02% |
172,292
-79,191
| -31% | -$1.78M |
|
582
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $3.53M | 0.02% |
92,611
+670
| +0.7% | +$25.9K |
|
583
iShares US Medical Devices ETF
IHI
$3.38B
| $3.52M | 0.02% |
55,990
+232
| +0.4% | +$14.8K |
|
584
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $3.51M | 0.02% |
39,284
+5,468
| +16% | +$495K |
|
585
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.69B
| $3.51M | 0.02% |
41,145
-35,268
| -46% | -$3.04M |
|
586
Sunrun
RUN
$2.46B
| $3.51M | 0.02% |
79,712
+6,129
| +8% | +$292K |
|
587
Sempra
SRE
$54.8B
| $3.51M | 0.02% |
55,458
+11,014
| +25% | +$727K |
|
588
Iridium Communications
IRDM
$5.29B
| $3.5M | 0.02% |
87,866
+2,411
| +3% | +$101K |
|
589
Public Storage
PSA
$61.3B
| $3.5M | 0.02% |
11,779
-2,299
| -16% | -$721K |
|
|
AGR
590
DELISTED
Avangrid, Inc.
AGR
| $3.5M | 0.02% |
71,998
+19,646
| +38% | +$1.03M |
|
591
Calamos Strategic Total Return Fund
CSQ
$3.35B
| $3.47M | 0.02% |
195,736
+10,201
| +5% | +$188K |
|
|
XLNX
592
DELISTED
Xilinx Inc
XLNX
| $3.46M | 0.02% |
22,898
+1,005
| +5% | +$147K |
|
593
Labcorp
LH
$25.9B
| $3.45M | 0.02% |
14,290
+3,722
| +35% | +$938K |
|
594
T. Rowe Price
TROW
$24.3B
| $3.45M | 0.02% |
17,544
+11,773
| +204% | +$2.48M |
|
595
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
| $3.45M | 0.02% |
43,977
+4,323
| +11% | +$347K |
|
596
Alcon
ALC
$35B
| $3.43M | 0.02% |
42,672
-1,363
| -3% | -$105K |
|
597
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.94B
| $3.42M | 0.02% |
165,776
+97,490
| +143% | +$2.02M |
|
598
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $3.4M | 0.02% |
50,203
+1,972
| +4% | +$127K |
|
599
Crane NXT
CXT
$3.07B
| $3.37M | 0.02% |
102,383
+4,739
| +5% | +$158K |
|
600
Royce Value Trust
RVT
$2.3B
| $3.34M | 0.02% |
185,558
+8,245
| +5% | +$152K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.